Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VLO vs MRNA✓SelectedUSD · MRNAVLO vs MRNA performance historyLatest closeAs of-2.66%11/16
Stock and ETF performance explorer

VLO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+220.9%
MRNA return
+179.0%
Excess return
+41.9%
Maximum drawdown
-41.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.7%-3.6%+1.0%-2.6%
7D+3.6%-20.0%+23.6%+3.7%
30D-16.9%-1.3%-15.6%-16.9%
3M+8.2%+240.0%-231.8%+7.0%
6M+48.7%+339.0%-290.2%+44.4%
YTD+130.5%+630.0%-499.5%+114.6%
1Y+107.7%+769.1%-661.3%+90.7%
All+220.9%+179.0%+41.9%+181.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling